Moderna CEO: COVID-19 Vaccine Surplus Possible In 2022

Moderna Inc. CEO Stephane Bancel said Friday that the company is on track to produce 1 billion doses of its COVID-19 vaccine this year, and that with manufacturers producing large quantities, there could be an oversupply in 2022.

During a virtual event on vaccine manufacturing, Bancel said the Massachusetts-based biotechnology company is also on pace to produce up to 1.4 billion next year, Reuters reported.

“Next year there is going to be way too many vaccines for people on the planet,” he said, noting that manufacturers should create as many vaccines as possible this year, according to Reuters. Read more…..


Chart of the Day

Icarus TV

Warren Buffett gives his greatest advice to young people and it might now be quite what you’d expect.

Share This Post

Leave a Reply